SavedAdd your journal

Journals / Ege Tıp Dergisi / 2022 / Cilt: 61 - Sayı: 2

Evaluation of tumoral glypican 3 mRNA level as a diagnostic and prognostic biomarker for hepatitis-b virus-associated hepatocellular carcinoma by an integrative transcriptomic meta-analysis and bioinformatics

Hepatit-B virüs ilişkili hepatosellüler karsinomda tümöral glipikan 3 mRNA seviyesinin diagnostik ve prognostik biyobelirteç olabilme potansiyelinin entegratif transkriptomik meta-analiz ve biyoinformatik ile değerlendirilmesi

Sevcan ATAY
Pages
249–258
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that GPC3 mRNA level could distinguish HCC from adjacent tissues with high specificity and sensitivity (AUC=0.9108;95%CI=0.08792-0.9424;p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study is to evaluate the potential of GPC3 mRNA level as a diagnostic and prognostic biomarker for HBV-associated HCC.
📊
Key Findings & Data:Materials and Methods: GPC3 mRNA expression in HBV-associated HCC tumor tissues compared to matched adjacent tissues was evaluated by integrative transcriptomic meta-analysis.
💡
Conclusion & Impact:It was found that GPC3 mRNA level could distinguish HCC from adjacent tissues with high specificity and sensitivity (AUC=0.9108;95%CI=0.08792-0.9424;p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study is to evaluate the potential of GPC3 mRNA level as a diagnostic and prognostic biomarker for HBV-associated HCC. Materials and Methods: GPC3 mRNA expression in HBV-associated HCC tumor tissues compared to matched adjacent tissues was evaluated by integrative transcriptomic meta-analysis. The results were validated in a different patient cohort and the possible associations between GPC3 mRNA level and the clinical variables were evaluated. Results: Transcriptomic data of HBV-associated HCC tissues (n=61) and matched adjacent tissues (n=61) from four datasets (GSE19665;GSE84402;GSE121248;GSE55092) were included in the meta-analysis. GPC3 mRNA level was found to be higher in tumors than adjacent tissues (fold change=12.88; p= 0;FDR=0). The result was validated in GSE14520, (HBV-associated HCC(n)=203; matched adjacent tissue(n)=203), (log-fold-change= 4.82; adj.p=1.43E-79). It was found that GPC3 mRNA level could distinguish HCC from adjacent tissues with high specificity and sensitivity (AUC=0.9108;95%CI=0.08792-0.9424;p

Özet

Amaç: Bu çalışmanın amacı HBV-ilişkili hepatosellüler kansinom hastalarında tümöral GPC3 mRNA seviyesinin diagnostik ve prognostik biyobelirteç olabilme potansiyelinin değerlendirilmesidir. Gereç ve Yöntem: Eşlenik tümör içermeyen karaciğer dokularına göre HBV-ilişkili HCC tümör dokularında GPC3 mRNA ekspresyonu entegratif transkriptomik meta-analiz yöntemi ile belirlendi. Sonuçlar farklı bir hasta kohortunda valide edildi ve GPC3 mRNA seviyesi ile klinik değişkenler arasındaki ilişki değerlendirildi. Bulgular: Meta-analize 4 farklı veri setinden (GSE19665;GSE84402;GSE121248;GSE55092) HBV-ilişkili hepatosellüler karsinom dokuları (n=61) ile eşlenik tümör içermeyen dokulara (n=61) ait transkriptomik veriler dahil edildi. GPC3 mRNA seviyesi’nin eşlenik dokulara göre tümörde daha yüksek olduğu bulundu (kat değişimi=12,88; p=0; FDR=0). Sonuçlar GSE14520 veri setinde (HBV-ilişkili HCC tümör (n)=203;eşlenik non-tümöral doku (n)=203) valide edildi (log-kat değişimi= 4,82; adj.p=1, 43 E-79). ROC analizi sonucunda GPC3 mRNA seviyesinin tümör dokularını tümör içermeyen eşlenik karaciğer dokularından yüksek spesifite ve sensitivite ile ayırabildiği bulundu (n=203;AUC=0,9108;%95CI=0,08792-0,9424;p

🔖

Cite This Article

ATAY, S. (2022). Evaluation of tumoral glypican 3 mRNA level as a diagnostic and prognostic biomarker for hepatitis-b virus-associated hepatocellular carcinoma by an integrative transcriptomic meta-analysis and bioinformatics. Ege Tıp Dergisi, Cilt: 61 - Sayı: 2, 249–258. https://ajindex.com/articles/495973

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kim E, Viatour P. Hepatocellular carcinoma: Old friends and new tricks. Experimental & Molecular Medicine 2020; 52: 1898-907
  2. Yang H-C, Kao J-H. Persistence of hepatitis b virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance. Emerging Microbes & Infections 2014; 3: 1-7
  3. Allweiss L, Dandri M. The role of cccdna in hbv maintenance. Viruses 2017; 9: 156
  4. Zhou F, Shang W, Yu X, Tian J. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. 2018; 38: 741-67
  5. Anatelli F, Chuang ST, Yang XJ, Wang HL. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy. Am J Clin Pathol 2008; 130: 219-23
  6. Sharov AA, Schlessinger D, Ko MS. Exatlas: An interactive online tool for meta-analysis of gene expression data. J Bioinform Comput Biol 2015; 13: 1550019
  7. Atay S. Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues. PeerJ 2020; 8: e10141
  8. Deng YB, Nagae G, Midorikawa Y, Yagi K, Tsutsumi S, Yamamoto S, et al. Identification of genes preferentially methylated in hepatitis c virus-related hepatocellular carcinoma. Cancer Sci 2010; 101: 1501-10
  9. Wang H, Huo X, Yang XR, He J, Cheng L, Wang N, et al. Stat3-mediated upregulation of lncrna hoxd-as1 as a cerna facilitates liver cancer metastasis by regulating sox4. Mol Cancer 2017; 16: 136
  10. Wang SM, Ooi LL, Hui KM. Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma. Clin Cancer Res 2007; 13: 6275-83
  11. Melis M, Diaz G, Kleiner DE, Zamboni F, Kabat J, Lai J, et al. Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis b virus-associated hepatocellular carcinoma. J Transl Med 2014; 12: 230
  12. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 2010; 70: 10202-12
  13. Wang Y-L, Zhu Z-J, Teng D-H, Yao Z, Gao W, Shen Z-Y. Glypican-3 expression and its relationship with recurrence of hcc after liver transplantation. World journal of gastroenterology 2012; 18: 2408-14
  14. Maurel M, Jalvy S, Ladeiro Y, Combe C, Vachet L, Sagliocco F, et al. A functional screening identifies five micrornas controlling glypican-3: Role of mir-1271 down-regulation in hepatocellular carcin